Message #24 From:
NewsBot Date: March 5, 2007 03:38:00 PM
AVAN News AVANT to Report Fourth Quarter and Year-End Fiscal 2006 Financial Results on March 7, 2007
NEEDHAM, Mass.--(BUSINESS WIRE)--AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) will release its fourth quarter and fiscal 2006 financial results before U.S. financial markets open on Wednesday, March 7, 2007.
AVANT executives will host a conference call and live audio webcast at 11:00 am ET that same day. To access the live call, dial 800-638-5495 (within the United States) or 617-614-3946 (outside the United States). The passcode for participants is 13145888. A replay will be available approximately two hours after the live call. To access the replay, dial 888-286-8010 (within the United States) or 617-801-6888 (outside the United States). The passcode I.D. # is 54794332. The replay will also be broadcast via the company’s website www.avantimmune.com approximately two hours after the live call.
About AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. discovers and develops innovative vaccines and therapeutics that harness the human immune system to prevent and treat disease. AVANT has three products on the market and five of AVANT’s products are in clinical development. AVANT’s pipeline includes products for biodefense, travelers’ vaccines, global health, and pandemic flu needs based on AVANT’s oral, rapid-protecting, single-dose and temperature stable vaccine technology.
